BEACTICA THERAPEUTICS AB

beactica-therapeutics-ab-logo

Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company is advancing a pipeline of novel small molecule therapeutics to treat genetically defined cancers with significant unmet clinical need. Beactica’s approach is centered around targeting disease proteins with synthetic lethality vulnerabilities by applying its molecular interaction-based drug discovery engine to generate novel small molecule across synergistic modalities, including allosteric modulators and targeted protein degraders (PROTACs). Beactica deliver value to patients and shareholders by advancing its programmes into early clinical trials.

#SimilarOrganizations #People #Financial #Website #More

BEACTICA THERAPEUTICS AB

Social Links:

Industry:
Health Care Medical Oncology

Founded:
2006-01-01

Address:
Uppsala, Uppsala Lan, Sweden

Country:
Sweden

Website Url:
http://www.beactica.com

Total Employee:
11+

Status:
Active

Contact:
46 18 56 08 80

Total Funding:
2.28 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Content Delivery Network JsDelivr


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

arctic-therapeutics-logo

Arctic Therapeutics

Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.

avstera-therapeutics-logo

Avstera Therapeutics

Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

nbe-therapeutics-logo

NBE-Therapeutics

NBE-Therapeutics is a biotech company that develops oncology treatments for cancer patients.

oncora-medical-logo

Oncora Medical

Oncora Medical is a digital health company integrating big data and machine learning into radiation oncology.

ryvu-logo

Ryvu

Ryvu is a biopharmaceutical company developing small molecule therapies that address clinical limitations of current treatments in oncology.

Current Employees Featured

ulf-bremberg_image

Ulf Bremberg
Ulf Bremberg Chief Scientific Officer @ Beactica Therapeutics AB
Chief Scientific Officer
2015-01-01

per-källblad_image

Per Källblad
Per Källblad Co-Founder and CEO @ Beactica Therapeutics AB
Co-Founder and CEO
2006-08-01

Founder


per-källblad_image

Per Källblad

Investors List

unionen_image

Unionen

Unionen investment in Venture Round - Beactica Therapeutics AB

almi-invest_image

Almi Invest

Almi Invest investment in Venture Round - Beactica Therapeutics AB

m2-capital-management_image

M2 Capital Management.

M2 Capital Management. investment in Venture Round - Beactica Therapeutics AB

unionen_image

Unionen

Unionen investment in Venture Round - Beactica Therapeutics AB

almi-invest_image

Almi Invest

Almi Invest investment in Venture Round - Beactica Therapeutics AB

easme_image

EASME - EU Executive Agency for SMEs

EASME - EU Executive Agency for SMEs investment in Grant - Beactica Therapeutics AB

vinnova_image

Vinnova

Vinnova investment in Grant - Beactica Therapeutics AB

almi-invest_image

Almi Invest

Almi Invest investment in Venture Round - Beactica Therapeutics AB

vinnova_image

Vinnova

Vinnova investment in Grant - Beactica Therapeutics AB

european-commission_image

European Commission

European Commission investment in Grant - Beactica Therapeutics AB

Official Site Inspections

http://www.beactica.com Semrush global rank: 11.3 M Semrush visits lastest month: 166

  • Host name: dedserv4006.levonline.com
  • IP address: 217.70.37.6
  • Location: Sweden
  • Latitude: 59.3247
  • Longitude: 18.056
  • Timezone: Europe/Stockholm

Loading ...

More informations about "Beactica Therapeutics AB"

Our Background - Beactica Therapeutics AB

Beactica's FBLG platform enables the generation of the world's first highly potent and selective allosteric USP7 inhibitor that later is outlicensed by Almac to Genentech in a deal worth $363 …See details»

Beactica Therapeutics AB - Crunchbase Company …

Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company is advancing a pipeline of novel small molecule …See details»

Beactica Therapeutics - LinkedIn

Beactica Therapeutics is a specialist drug discovery and development company, committed to the fight against cancer. Beactica is advancing a proprietary pipeline of first-in-class therapeutics by ...See details»

Investors - Beactica Therapeutics AB

Beactica Therapeutics is a specialist precision oncology company, founded in 2006 as a spin-out from Uppsala University in Sweden. With a precise and targeted approach, we bring highly …See details»

Beactica Therapeutics 2025 Company Profile: …

SWElife, Flerie, M2Capital, Paab, and Horizon 2020 SME Instrument are 5 of 11 investors who have invested in Beactica Therapeutics. Who are Beactica Therapeutics’s competitors? Atomwise , Mitobridge , Cellestia , Theolytics , …See details»

Beactica Therapeutics AB - Funding, Financials, Valuation & Investors

Beactica Therapeutics is a precision oncology company developing novel small molecule therapeutics to treat genetically defined cancers. New. Resources. ... How much funding has …See details»

Beactica Therapeutics AB Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Beactica Therapeutics AB of Uppsala, Uppsala. Get the latest business insights from Dun & Bradstreet.See details»

Beactica Therapeutics - Org Chart, Teams, Culture & Jobs - The Org

Beactica Therapeutics AB is a precision oncology company committed to the fight against cancer. The company is advancing a pipeline of novel small molecule therapeutics to treat genetically …See details»

Beactica Therapeutics AB - Cision News

Beactica Therapeutics announces the selection of BEA-17 as a preclinical candidate Tue, Sep 05, 2023 07:30 CET. Beactica Therapeutics AB, the Swedish precision oncology company, today …See details»

Beactica Therapeutics AB - Contacts, Employees, Board

Beactica Therapeutics is a precision oncology company developing novel small molecule therapeutics to treat genetically defined cancers. ... Experience the new Crunchbase, powered …See details»

Beactica AB - Uppsala, Sweden - bionity.com

Apr 29, 2011 Beactica AB is a specialist drug discovery company, utilising its proprietary methodologies to evaluate the biophysical interaction of molecules in order to generate novel …See details»

Our Vision and Culture - Beactica Therapeutics AB

Beactica's vision is to create novel medicines that improve the prospects for patients suffering from life-threatening diseases. We create novel medicines that will benefit patients across the …See details»

beactica.com Reviews: Is this site a scam or legit?

Beactica.com Review. The Scam Detector website Validator gives beactica.com a medium-high trust score on the platform: 77.4.It signals that the business is best defined by the following …See details»

Beactica Company Profile - Office Locations, Competitors ... - Craft

Beactica is a company that specializes in fragment-based drug discovery using surface plasmon resonance (SPR) biosensor technology. It utilizes its proprietary methodologies to evaluate the …See details»

Beactica | VentureRadar

Beactica Therapeutics AB is a specialist drug discovery company, utilising its proprietary methodologies to evaluate the interactions of molecules in order to generate novel …See details»

Beactica Therapeutics AB - DevelopmentAid

Beactica Therapeutics AB — Consulting Organization from Sweden, has experience with The Seventh Framework Programme, Horizon 2020 (2014 - 2020), Horizon Europe (2021 - 2027), …See details»

Beactica - Overview, News & Similar companies | ZoomInfo.com

Feb 13, 2024 Who is Beactica. Beactica Therapeutics AB is a specialist drug discovery and development company, committed to the fight against cancer. Beactica is advancing a pro …See details»

Beactica Therapeutics’ small molecule platform enables the …

Oncology, Beactica offers partnerships using its proprietary drug discovery platform. Founded in 2006 based on research carried out at Uppsala University, Beactica has established a …See details»

Beactica Therapeutics announces the selection of BEA-17 as a ...

Sep 5, 2023 Beactica Therapeutics AB is a privately held precision oncology company committed to the fight against cancer. The company is advancing a pipeline of novel small …See details»

linkstock.net © 2022. All rights reserved